Proinnate Numbing Cream
NDC Package 60771-0039-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Proinnate Numbing Cream (menthol) cream is a medication used as For the temporary relief ofpain and itching associated withminor burns, sunburn, minorcuts, scrapes, and insect bites. This formulation utilizes a cream delivery system. Marketed by Guangzhou Haishi Biological Technology Co., Ltd., this product is identified by NDC 60771-0039 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
60771-0039-1
Package Description
30 g in 1 JAR
Product Code
60771-0039
11-Digit Billing Format
60771003901
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Proinnate Numbing Cream
Non-Proprietary Name
Menthol
Substance Name
Menthol
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MENTHOL 10 g/100g
Usage Information
This product is used as For the temporary relief ofpain and itching associated withminor burns, sunburn, minorcuts, scrapes, and insect bites.. 1.Before use, do a patch test toensure it suits your skin andnumbs effecitively. 2.Clean your hands andtreatment area thoroughly withmild soap and warm water. Drythem afterward. 3.Apply a THICK layer ofnumbing cream to the treatmentarea, making sure to cover boththe tattooed area and itssurroundings.4.Wrap the area securely withplastic wrap and leave it on for40-50 minutes for the bestresults (keeping it on longergives better effects).5.Remove any remaining creamand wait an additional 5 minutesfor the numbing sensation toreach its peak.

Regulatory & Marketing

Labeler Name
Guangzhou Haishi Biological Technology Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-10-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60771-0039-1 identifies a specific commercial package of 30 g in 1 jar of Proinnate Numbing Cream, a human over the counter drug labeled by Guangzhou Haishi Biological Technology Co., Ltd.. This cream is formulated for topical use and contains menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Haishi Biological Technology Co., Ltd. on October 10, 2025. The current certification is valid through December 31, 2026.

How is this Guangzhou Haishi Biological Technology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60771003901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
60771-0039-1
11-Digit CMS (5-4-2)
60771-0039-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.